Tag Directory / PHARMACEUTICALS     showing 21–35 of 35   RSS



Amazon will start dispensing prescription drugs through vending machines

Matt Tate / engadget - Amazon’s quest to become a genuine all-in-one healthcare solution has already seen it commit to same-day prescription deliveries, but visitors to its One Medical offices can now pick up their medication from a vending machine right after an appointment.Am…

#innovation #ecommerce #digitalhealth #amazon #pharmaceuticals #california

4 months / techxplore

4 months / cnbc


Back to Top / Wednesday, October 8, 2025, 12:22 pm / permalink 15027 / 6 stories in 4 months


Nobel Prize awarded to trio for immune tolerance research

Colin Ryan / siliconrepublic - The trio of new Nobel laureates were awarded the prize for their research on the immune system and how it tolerates our own tissues.Read more: Nobel Prize awarded to trio for immune tolerance research

#innovation #biotech #science #health #biology #pharmaceuticals #medicine

5 months / google

5 months / nobelprize


Back to Top / Monday, October 6, 2025, 8:21 am / permalink 14986 / 6 stories in 5 months


Bonkers CDC vaccine meeting ends with vote to keep COVID shot access

Beth Mole / arstechnica - A push to require prescriptions for every COVID shot failed in a split vote.

#health #government #pharmaceuticals #law

Back to Top / Friday, September 19, 2025, 5:20 pm / permalink 14755 / 10 stories in 5 months


Vaccine Panel Stacked by RFK Jr. Recommends Delaying MMRV Immunization

Emily Mullin / wired - The vaccine advisory group ACIP, not all members of which seemed to know what the group does, recommended to the CDC that combined MMRV shots not be given before age 4.

#digitalhealth #health #government #pharmaceuticals

Back to Top / Thursday, September 18, 2025, 8:20 pm / permalink 14721 / 8 stories in 5 months


ArcaScience raises $7M to expand AI benefit risk platform in drug development

Duncan Riley / siliconangle - French artificial intelligence healthtech startup ArcaScience SAS revealed today that it has raised $7 million in new funding to expand into the U.S. and the U.K., launch a patient-facing solution for pediatric brain cancer and dermatological diseases,and…

#ai #vc #biotech #pharmaceuticals

Back to Top / Wednesday, September 3, 2025, 4:20 am / permalink 13642 / 2 stories in 6 months


Novo Nordisk halves US price of Ozempic - Financial Times

google - Novo Nordisk halves US price of Ozempic Financial Times

#business #us #pricing #pharmaceuticals

6 months / google


Back to Top / Monday, August 18, 2025, 2:21 pm / permalink 12548 / 1 stories in 6 months


Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results

Emily Mullin / wired - In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.

#health #stockmarket #business #pharmaceuticals

Back to Top / Thursday, August 7, 2025, 10:21 am / permalink 11840 / 1 stories in 6 months


Novo Nordisk Forecast Slashed, Shares Plunge Sharply

Facing a perfect storm of disappointing weight‐loss drug sales and investor unease, Novo Nordisk has dramatically downgraded its future forecasts. The fallout has triggered a record plunge in shares while industry watchers and investors scrutinize how the pharmaceutical giant plans to navigate these choppy waters amid high-stakes market expectations.

#stockmarket #earnings #finance #pharmaceuticals

7 months / google


Back to Top / Tuesday, July 29, 2025, 8:20 am / permalink 11122 / 1 stories in 7 months


EU Rejects Sarepta-Roche Gene Therapy, Triggering Market Plunge

European regulators have denied approval for Sarepta-Roche’s gene therapy candidate, Elevidys, sending the company’s shares tumbling. The decision highlights the regulatory hurdles facing cutting‐edge biotech and the ensuing financial backlash, leaving investors to wonder if innovation comes at too high a price.

#biotech #stockmarket #europe #pharmaceuticals

Back to Top / Friday, July 25, 2025, 10:21 am / permalink 10913 / 0 stories in 7 months


FDA’s ‘Elsa’ AI For Faster Drug Approvals Under Fire for Hallucinating Studies, Highlighting Widespread Reliability Risks

Markus Kasanmascheff / winbuzzer - The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of unreliable AI in high-stakes roles.The post FDA’s ‘Elsa’ AI For Faster Drug Approvals Under Fire for Hallucinating Studies, Highlighting …

#ai #science #aiethics #pharmaceuticals

Back to Top / Thursday, July 24, 2025, 8:21 am / permalink 10819 / 2 stories in 7 months


FDA employees say the agency's Elsa generative AI hallucinates entire studies

Anna Washenko / engadget - Current and former members of the FDA told CNN about issues with the Elsa generative AI tool unveiled by the federal agency last month. Three employees said that in practice, Elsa has hallucinated nonexistent studies or misrepresented real research. "Anyt…

#ai #digitalhealth #aiethics #pharmaceuticals

Back to Top / Wednesday, July 23, 2025, 4:21 pm / permalink 10772 / 2 stories in 7 months


Agentic AI startup Asepha bags $4M seed funding to automate pharmacy operations

Mike Wheatley / siliconangle - Pharmacy automation startup Asepha AI says it’s ready to help drug dispensaries overcome their understaffing problems after closing on a $4 million seed funding round today. The round was led by Glasswing Ventures and Core Innovation Capital and saw parti…

#startups #vc #automation #pharmaceuticals

Back to Top / Monday, July 14, 2025, 9:21 am / permalink 9997 / 2 stories in 7 months


FDA restricts COVID vaccine approvals to seniors

In an unexpected policy pivot, the FDA is tightening the reins on COVID vaccine access by limiting new approvals to those over 65 and other high‐risk groups. Critics argue that while the move may streamline regulatory efforts, it effectively sidelines a broader segment of the public—leaving many with fewer options.

#health #government #pharmaceuticals

Back to Top / Tuesday, May 20, 2025, 4:20 pm / permalink 5114 / 2 stories in 9 months


Biden’s Aggressive Prostate Cancer Diagnosis Confirmed Amid Growing Concern

Recent reports reveal that President Biden has been diagnosed with an aggressive form of stage IV prostate cancer. Health experts warn that the seriousness of the illness could impact the nation’s leader, stirring political debate and public concern, while officials monitor his medical condition closely.

#health #politics #us #pharmaceuticals

Back to Top / Sunday, May 18, 2025, 5:20 pm / permalink 4990 / 0 stories in 9 months


OpenAI-FDA Talks Boost AI’s Role in Drug Evaluations

High-ranking OpenAI officials have been in discussions with FDA representatives about integrating AI into drug evaluation processes. Both accounts reference a project cderGPT, underscoring industry and regulatory momentum towards AI-driven reforms in healthcare, all while navigating cautious optimism and bureaucratic rigor.

#ai #openai #government #pharmaceuticals

Back to Top / Wednesday, May 7, 2025, 5:20 pm / permalink 4264 / 5 stories in 9 months


Back to Top


PHARMACEUTICALS Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.



More Top Stories...


Oracle and OpenAI scrap Texas data-center expansion; Meta eyes the spare capacity

Oracle and OpenAI have abandoned plans to expand a flagship Texas data center, leaving substantial compute capacity up for grabs. Nvidia reportedly brokered interest from Meta to take the unused slots as OpenAI downscales that particular buildout, a move that rattled markets and highlights shifting demand for large-scale on-prem AI infrastructure. More...


OpenAI launches Codex Security agent to automatically detect software vulnerabilities

OpenAI rolled out Codex Security, an AI agent that scans codebases to find complex vulnerabilities, suggests actionable fixes, and uses sandbox testing to limit false positives. The tool has already flagged issues in major projects and aims to compete with traditional application security tooling by automating deep, contextual code review. More...


Google releases Workspace CLI enabling AI agents to access Gmail, Drive, Calendar

Google has shipped an open-source Workspace CLI that gives AI agents like OpenClaw programmatic access to Gmail, Drive, Calendar and other Workspace services via a built-in MCP server. The tool standardizes agent integration, making it easier — and slightly creepier — for automated assistants to act on users’ behalf across core productivity apps. More...


CISA, Google and US agencies flag Coruna iOS exploit kit in active use

U.S. agencies and security teams have raised alarms about “Coruna,” a powerful iOS exploit kit tied to spyware and crypto-theft campaigns. Google’s threat unit traced the toolkit’s activity while CISA ordered federal mitigations for the targeted iOS flaws, urging rapid patching as investigators hunt for origins and victims. More...


U.S.-Iran strikes roil markets and satellite imagery firms amid fresh attacks

A recent round of retaliatory strikes between the U.S. and Iran has immediate spillovers: defense analytics firm shares jumped on expected demand, major chipmaker stock fell amid geopolitical jitters, and a commercial satellite imagery provider paused public image distribution to prevent adversarial use for battle-damage assessment. Markets and imagery services scrambled for damage control. More...



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.